Taken directly from the American College of Cardiology One glass of wine, beer or other alcoholic beverage may significantly increase the risk of an atrial…View More HOLIDAY Monitors: Alcohol Consumption Significantly Increases Risk of AFib Episode
By Saadia Aslam A study by Caleyachetty et al has prospectively identified ethnicity-specific BMI cutoffs for obesity based on the risk of type 2 diabetes…View More Are ethnicity-specific BMI cutoffs now needed for type 2 diabetes risk in England?
A study by Chorba et al investigate Deep learning approaches in detect heart murmurs and clinically significant valvular heart disease, using recording from digital stethoscopes.…View More When detecting heart murmurs, has Artificial Intelligence surpassed the Consultant Cardiologist?
By Ahmed El-Medany Disruption to training due to the COVID-19 pandemic has led to difficulties for some trainees in acquiring the competencies required to progress,…View More COVID-19 and Cardiology ARCP outcomes: a summary for trainers and trainees
By Dr Rebecca Dobson, BCS Women in Cardiology Lead and Consultant Cardiologist at the Liverpool Heart and Chest Hospital A bold and ambitious statement from…View More The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Summary taken directly from the American College of CardiologyWritten by: Debabrata Mukherjee, MD, FACC Quick Takes Transseptal MViV in selected patients at high surgical risk…View More MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes
By Ahmed El-Medany A retrospective cohort study by Dawwas et al reports that DOACs, compared with warfarin, were associated with lower risks for ischemic stroke…View More DOACs vs. warfarin in valvular atrial fibrillation
By Saadia Aslam An FDA review of study findings showed a potential increased risk of cardiac arrhythmias in patients with pre-existing cardiac disease who are…View More Lamotrigine may be associated with increased risk of cardiac arrhythmias, FDA warns
(Taken from Expert Analysis- ACC) This secondary analysis from the EMPEROR-Reduced trial shows that use of empagliflozin reduces the risk of CV death or HF…View More Beyond Diabetes: The Impact of Empagliflozin in Heart Failure with Reduced Ejection Fraction
By Saadia Aslam Despite an upsurge in the incidence of atherosclerotic cardiovascular diseases (ASCVD) among young adults, the attributable risk of recreational substance use among…View More Recreational substances associated with a higher likelihood of premature atherosclerotic cardiovascular disease